drugset / Trial / NCT00467636

Insulin Therapy in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations

NCT00467636

RandomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the effect of preventing hyperglycaemia in patients admitted to hospital with acute exacerbations of chronic pulmonary disease.

Timeline

Start
2007-07
Primary completion
2009-05
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin glulisine Protein / enzyme biologic 0.1 iu/kg Subcutaneous
Subject Insulin glulisine Protein / enzyme biologic 0.2 iu/kg Subcutaneous